NLRP3 Inflammasome Activation of Mast Cells by Estrogen via the Nuclear-Initiated Signaling Pathway Contributes to the Development of Endometriosis

Endometriosis is an estrogen-dependent gynecological disease. The pathogenesis of endometriosis remains controversial, although it is generally accepted that the inflammatory immune response plays a crucial role in this process. Mast cells (MCs) are multifunctional innate immune cells that accumulat...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 12; p. 749979
Main Authors Guo, Xinyue, Xu, Xinxin, Li, Tiantian, Yu, Qin, Wang, Jianzhang, Chen, Yichen, Ding, Shaojie, Zhu, Libo, Zou, Gen, Zhang, Xinmei
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 22.09.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Endometriosis is an estrogen-dependent gynecological disease. The pathogenesis of endometriosis remains controversial, although it is generally accepted that the inflammatory immune response plays a crucial role in this process. Mast cells (MCs) are multifunctional innate immune cells that accumulate in endometriotic lesions. However, the molecular mechanism by which estrogen modulates MCs in the development of endometriosis is not well understood. Here we report that estrogen can induce the expression of NOD-like receptor family pyrin domain containing 3 (NLRP3) through estrogen receptor (ER)-α via the estrogen responsive element (ERE) in MCs. Such transcriptional regulation is necessary for the activation of NLRP3 inflammasome and the production of mature interleukin (IL)-1β in MCs. Targeted inhibition of NLRP3 significantly restrained lesion progression and fibrogenesis in a mouse model of endometriosis. Collectively, these findings suggest that MCs contribute to the development of endometriosis through NLRP3 inflammasome activation mediated by nuclear-initiated estrogen signaling pathway.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Reviewed by: Zheng Wei, Yale University, United States; Peng Jin, New York University, United States
This article was submitted to Inflammation, a section of the journal Frontiers in Immunology
Edited by: Jixin Zhong, Huazhong University of Science and Technology, China
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2021.749979